30 July 2020 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: Volumetric brain MR imaging typically has long acquisition times. We sought to evaluate an ultrafast MPRAGE sequence based on Wave-CAIPI (Wave-MPRAGE) compared with standard MPRAGE for evaluation of regional brain tissue volumes. MATERIALS AND METHODS: We performed scan-rescan experiments in 10 healthy volunteers to evaluate the intraindividual variability of the brain volumes measured using the standard and Wave-MPRAGE sequences. We then evaluated 43 consecutive patients undergoing brain MR imaging. Patients underwent 3T brain MR imaging, including a standard MPRAGE sequence (acceleration factor [R] = 2, acquisition time [TA] = 5.2 minutes) and an ultrafast Wave-MPRAGE sequence (R = 9, TA = 1.15 minutes for the 32-channel coil; R = 6, TA = 1.75 minutes for the 20-channel coil). Automated segmentation of regional brain volume was performed. Two radiologists evaluated regional brain atrophy using semiquantitative visual rating scales. RESULTS: The mean absolute symmetrized percent change in the healthy volunteers participating in the scan-rescan experiments was not statistically different in any brain region for both the standard and Wave-MPRAGE sequences. In the patients undergoing evaluation for neurodegenerative disease, the Dice coefficient of similarity between volumetric measurements obtained from standard and Wave-MPRAGE ranged from 0.86 to 0.95. Similarly, for all regions, the absolute symmetrized percent change for brain volume and cortical thickness showed <6% difference between the 2 sequences. In the semiquantitative visual comparison, the differences between the 2 radiologists’ scores were not clinically or statistically significant. CONCLUSIONS: Brain volumes estimated using ultrafast Wave-MPRAGE show low intraindividual variability and are comparable with those estimated using standard MPRAGE in patients undergoing clinical evaluation for suspected neurodegenerative disease.
26 January 2023 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: A scout accelerated motion estimation and reduction (SAMER) framework has been developed for efficient retrospective motion correction. The goal of this study was to perform an initial evaluation of SAMER in a series of clinical brain MR imaging examinations. MATERIALS AND METHODS: Ninety-seven patients who underwent MR imaging in the inpatient and emergency department settings were included in the study. SAMER motion correction was retrospectively applied to an accelerated T1-weighted MPRAGE sequence that was included in brain MR imaging examinations performed with and without contrast. Two blinded neuroradiologists graded images with and without SAMER motion correction on a 5-tier motion severity scale (none = 1, minimal = 2, mild = 3, moderate = 4, severe = 5). RESULTS: The median SAMER reconstruction time was 1 minute 47 seconds. SAMER motion correction significantly improved overall motion grades across all examinations (P < .005). Motion artifacts were reduced in 28% of cases, unchanged in 64% of cases, and increased in 8% of cases. SAMER improved motion grades in 100% of moderate motion cases and 75% of severe motion cases. Sixty-nine percent of nondiagnostic motion cases (grades 4 and 5) were considered diagnostic after SAMER motion correction. For cases with minimal or no motion, SAMER had negligible impact on the overall motion grade. For cases with mild, moderate, and severe motion, SAMER improved the motion grade by an average of 0.3 (SD, 0.5), 1.1 (SD, 0.3), and 1.1 (SD, 0.8) grades, respectively. CONCLUSIONS: SAMER improved the diagnostic image quality of clinical brain MR imaging examinations with motion artifacts. The improvement was most pronounced for cases with moderate or severe motion.
28 September 2024 in NeuroImage
Three-dimensional (3D) T1-weighted MRI sequences such as the magnetization prepared rapid gradient echo (MPRAGE) sequence are important for assessing regional cortical atrophy in the clinical evaluation of dementia but have long acquisition times and are prone to motion artifact. The recently developed Scout Accelerated Motion Estimation and Reduction (SAMER) retrospective motion correction method addresses motion artifact within clinically-acceptable computation times and has been validated through qualitative evaluation in inpatient and emergency settings. We evaluated the quantitative accuracy of morphometric analysis of SAMER motion-corrected compared to non-motion-corrected MPRAGE images by estimating cortical volume and thickness across neuroanatomical regions in two subject groups: (1) healthy volunteers and (2) patients undergoing evaluation for dementia. In part (1), we used a set of 108 MPRAGE reconstructed images derived from 12 healthy volunteers to systematically assess the effectiveness of SAMER in correcting varying degrees of motion corruption, ranging from mild to severe. In part (2), 29 patients who were scheduled for brain MRI with memory loss protocol and had motion corruption on their clinical MPRAGE scans were prospectively enrolled. In part (1), SAMER resulted in effective correction of motion-induced cortical volume and thickness reductions. We observed systematic increases in the estimated cortical volume and thickness across all neuroanatomical regions and a relative reduction in percent error values compared to reference standard scans of up to 66 % for the cerebral white matter volume. In part (2), SAMER resulted in statistically significant volume increases across anatomical regions, with the most pronounced increases seen in the parietal and temporal lobes, and general reductions in percent error relative to reference standard clinical scans. SAMER improves the accuracy of morphometry through systematic increases and recovery of the estimated cortical volume and cortical thickness following motion correction, which may affect the evaluation of regional cortical atrophy in patients undergoing evaluation for dementia.
2 April 2026 in American Journal of Neuroradiology
8 October 2025 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: Motion artifacts remain a key limitation in brain MRI, particularly during 3D acquisitions in cognitively impaired patients. Most deep learning (DL) reconstruction techniques improve signal-to-noise ratio but lack explicit mechanisms to correct for motion. This study aims to validate a DL reconstruction method that integrates retrospective motion correction into the reconstruction pipeline for 3D T1-weighted brain MRI. MATERIALS AND METHODS: This prospective, intra-individual comparison study included a controlled-motion cohort of healthy volunteers and a clinical cohort of patients undergoing evaluation for memory loss. Each cohort was scanned at distinct imaging sites between October 2022 and August 2023 in staggered periods. All participants underwent 4-fold under-sampled 3D magnetization-prepared rapid gradient-echo imaging with integrated Scout Accelerated Motion Estimation and Reduction (SAMER) acquisition. Image volumes were reconstructed using standard-of-care methods and the proposed DL approach. Quantitative morphometric accuracy was assessed by comparing brain segmentation results of instructed-motion scans to motion-free reference scans in the healthy volunteers. Image quality was rated by two board-certified neuroradiologists using a five-point Likert scale. Statistical analysis included Wilcoxon tests and intraclass correlation coefficients. RESULTS: A total of 41 participants (15 women [37%]; mean age, 58 years) and 154 image volumes were evaluated. The DL-based method with integrated motion correction significantly reduced segmentation error under moderate and severe motion (12.4% to 3.5% and 44.2% to 12.5%, respectively; P < .001). Visual ratings showed improved scores across all criteria compared with standard reconstructions (overall image quality, 4.26 ± 0.72 vs. 3.59 ± 0.82; P < .001). In 47% of cases, motion artifact severity was improved following DL-based processing. Inter-reader agreement ranged from moderate to substantial. CONCLUSIONS: Motion-informed DL reconstruction improved both morphometric accuracy and perceived image quality in 3D T1-weighted brain MRI. This technique may enhance diagnostic utility and reduce scan failure rates in motion-prone patients with cognitive impairment. ABBREVIATIONS: AD = Alzheimer’s disease; DL = deep learning; ICC = intra-class correlation coefficient; SAMER = scout accelerated motion estimation and reduction